One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma. Inoue K, Shiokawa M, Kunimatsu-Sanuki S, Nozaki N, et al. J Ocul Pharmacol Ther 2022 May 25. doi: 10.1089/jop.2021.0122.

Read + Share

Amedeo Smart

Independent Medical Education

Inoue K, Shiokawa M, Kunimatsu-Sanuki S, Nozaki N, et al. One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma. J Ocul Pharmacol Ther 2022 May 25. doi: 10.1089/jop.2021.0122.
PMID: 35613407